1. Home
  2. BOLT vs AMS Comparison

BOLT vs AMS Comparison

Compare BOLT & AMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • AMS
  • Stock Information
  • Founded
  • BOLT 2015
  • AMS 1980
  • Country
  • BOLT United States
  • AMS United States
  • Employees
  • BOLT N/A
  • AMS N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • AMS Medical Specialities
  • Sector
  • BOLT Health Care
  • AMS Health Care
  • Exchange
  • BOLT Nasdaq
  • AMS Nasdaq
  • Market Cap
  • BOLT 25.3M
  • AMS 21.1M
  • IPO Year
  • BOLT 2021
  • AMS N/A
  • Fundamental
  • Price
  • BOLT $0.52
  • AMS $3.22
  • Analyst Decision
  • BOLT Hold
  • AMS
  • Analyst Count
  • BOLT 5
  • AMS 0
  • Target Price
  • BOLT $1.25
  • AMS N/A
  • AVG Volume (30 Days)
  • BOLT 168.8K
  • AMS 14.9K
  • Earning Date
  • BOLT 11-12-2024
  • AMS 11-13-2024
  • Dividend Yield
  • BOLT N/A
  • AMS N/A
  • EPS Growth
  • BOLT N/A
  • AMS 779.12
  • EPS
  • BOLT N/A
  • AMS 0.61
  • Revenue
  • BOLT $9,779,000.00
  • AMS $24,969,000.00
  • Revenue This Year
  • BOLT $9.87
  • AMS $29.39
  • Revenue Next Year
  • BOLT N/A
  • AMS $16.22
  • P/E Ratio
  • BOLT N/A
  • AMS $5.58
  • Revenue Growth
  • BOLT 35.86
  • AMS 20.83
  • 52 Week Low
  • BOLT $0.50
  • AMS $2.33
  • 52 Week High
  • BOLT $1.56
  • AMS $4.60
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 38.20
  • AMS 47.26
  • Support Level
  • BOLT $0.50
  • AMS $3.15
  • Resistance Level
  • BOLT $0.59
  • AMS $3.59
  • Average True Range (ATR)
  • BOLT 0.03
  • AMS 0.15
  • MACD
  • BOLT -0.00
  • AMS 0.00
  • Stochastic Oscillator
  • BOLT 24.49
  • AMS 17.78

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About AMS American Shared Hospital Services

American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.

Share on Social Networks: